[
  {
    "ts": "2026-02-13T09:18:57+00:00",
    "headline": "Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus",
    "summary": "Bristol-Myers Squibb (NYSE:BMY) has outlined a broad pipeline refresh that includes multiple recent product launches and the announcement of a new R&D facility. The company has agreed to acquire Orbital Therapeutics, expanding its presence in RNA based medicines. New collaborations with BioNTech and Philochem target next generation cancer and immunology treatments. Management has paired these moves with plans for major cost savings and added manufacturing capacity. Bristol-Myers Squibb,...",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-resets-pipeline-091857977.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9fe22cff-a259-3593-80a8-14693114d5f7",
      "content": {
        "id": "9fe22cff-a259-3593-80a8-14693114d5f7",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus",
        "description": "",
        "summary": "Bristol-Myers Squibb (NYSE:BMY) has outlined a broad pipeline refresh that includes multiple recent product launches and the announcement of a new R&D facility. The company has agreed to acquire Orbital Therapeutics, expanding its presence in RNA based medicines. New collaborations with BioNTech and Philochem target next generation cancer and immunology treatments. Management has paired these moves with plans for major cost savings and added manufacturing capacity. Bristol-Myers Squibb,...",
        "pubDate": "2026-02-13T09:18:57Z",
        "displayTime": "2026-02-13T09:18:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-resets-pipeline-091857977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-resets-pipeline-091857977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]